Selected research
Industry Research
Inhalation Formulation Development Services Industry Research Report 2026
Market perspective
The global Inhalation Formulation Development Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Inhalation Formulation Development Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Inhalation Formulation Development Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Inhalation Formulation Development Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Inhalation Formulation Development Services include Hovione, Vectura, Experic, Nanopharm, CritiTech Particle Engineering Solutions, Upperton, Tepnel, Intertek and Quotient Sciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Inhalation Formulation Development Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Inhalation Formulation Development Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhalation Formulation Development Services Market by Company
Hovione
Vectura
Experic
Nanopharm
CritiTech Particle Engineering Solutions
Upperton
Tepnel
Intertek
Quotient Sciences
Medicilon
Leadingpharm Medical Technology
Lonza
Inhalation Formulation Development Services Segment by Type
Liquid Inhaler Development
Dry Powder Inhaler Development
Inhalation Formulation Development Services Segment by Application
Pharmaceutical Companies
Research Institutes
Others
Inhalation Formulation Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Formulation Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation Formulation Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Formulation Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Inhalation Formulation Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Inhaler Development
- Dry Powder Inhaler Development
Applications
- Pharmaceutical Companies
- Research Institutes
- Others
Companies covered
- Hovione
- Vectura
- Experic
- Nanopharm
- CritiTech Particle Engineering Solutions
- Upperton
- Tepnel
- Intertek
- Quotient Sciences
- Medicilon
- Leadingpharm Medical Technology
- Lonza
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Inhalation Formulation Development Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Liquid Inhaler Development
- 2.2.3 Dry Powder Inhaler Development
- 2.3 Inhalation Formulation Development Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Research Institutes
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Inhalation Formulation Development Services Breakdown Data by Type
- 3.1 Global Inhalation Formulation Development Services Historic Market Size by Type (2021-2026)
- 3.2 Global Inhalation Formulation Development Services Forecasted Market Size by Type (2027-2032)
4 Inhalation Formulation Development Services Breakdown Data by Application
- 4.1 Global Inhalation Formulation Development Services Historic Market Size by Application (2021-2026)
- 4.2 Global Inhalation Formulation Development Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Inhalation Formulation Development Services Market Perspective (2021-2032)
- 5.2 Global Inhalation Formulation Development Services Growth Trends by Region
- 5.2.1 Global Inhalation Formulation Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Inhalation Formulation Development Services Historic Market Size by Region (2021-2026)
- 5.2.3 Inhalation Formulation Development Services Forecasted Market Size by Region (2027-2032)
- 5.3 Inhalation Formulation Development Services Market Dynamics
- 5.3.1 Inhalation Formulation Development Services Industry Trends
- 5.3.2 Inhalation Formulation Development Services Market Drivers
- 5.3.3 Inhalation Formulation Development Services Market Challenges
- 5.3.4 Inhalation Formulation Development Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Inhalation Formulation Development Services Players by Revenue
- 6.1.1 Global Top Inhalation Formulation Development Services Players by Revenue (2021-2026)
- 6.1.2 Global Inhalation Formulation Development Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Inhalation Formulation Development Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Inhalation Formulation Development Services Head Office and Area Served
- 6.4 Global Inhalation Formulation Development Services Players, Product Type & Application
- 6.5 Global Inhalation Formulation Development Services Manufacturers Established Date
- 6.6 Global Inhalation Formulation Development Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Inhalation Formulation Development Services Market Size (2021-2032)
- 7.2 North America Inhalation Formulation Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Inhalation Formulation Development Services Market Size by Country (2021-2026)
- 7.4 North America Inhalation Formulation Development Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Inhalation Formulation Development Services Market Size (2021-2032)
- 8.2 Europe Inhalation Formulation Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Inhalation Formulation Development Services Market Size by Country (2021-2026)
- 8.4 Europe Inhalation Formulation Development Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Inhalation Formulation Development Services Market Size (2021-2032)
- 9.2 Asia-Pacific Inhalation Formulation Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Inhalation Formulation Development Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Inhalation Formulation Development Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Inhalation Formulation Development Services Market Size (2021-2032)
- 10.2 South America Inhalation Formulation Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Inhalation Formulation Development Services Market Size by Country (2021-2026)
- 10.4 South America Inhalation Formulation Development Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Inhalation Formulation Development Services Market Size (2021-2032)
- 11.2 Middle East & Africa Inhalation Formulation Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Inhalation Formulation Development Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Inhalation Formulation Development Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Hovione
- 12.1.1 Hovione Company Information
- 12.1.2 Hovione Business Overview
- 12.1.3 Hovione Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.1.4 Hovione Inhalation Formulation Development Services Product Portfolio
- 12.1.5 Hovione Recent Developments
- 12.2 Vectura
- 12.2.1 Vectura Company Information
- 12.2.2 Vectura Business Overview
- 12.2.3 Vectura Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.2.4 Vectura Inhalation Formulation Development Services Product Portfolio
- 12.2.5 Vectura Recent Developments
- 12.3 Experic
- 12.3.1 Experic Company Information
- 12.3.2 Experic Business Overview
- 12.3.3 Experic Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.3.4 Experic Inhalation Formulation Development Services Product Portfolio
- 12.3.5 Experic Recent Developments
- 12.4 Nanopharm
- 12.4.1 Nanopharm Company Information
- 12.4.2 Nanopharm Business Overview
- 12.4.3 Nanopharm Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.4.4 Nanopharm Inhalation Formulation Development Services Product Portfolio
- 12.4.5 Nanopharm Recent Developments
- 12.5 CritiTech Particle Engineering Solutions
- 12.5.1 CritiTech Particle Engineering Solutions Company Information
- 12.5.2 CritiTech Particle Engineering Solutions Business Overview
- 12.5.3 CritiTech Particle Engineering Solutions Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.5.4 CritiTech Particle Engineering Solutions Inhalation Formulation Development Services Product Portfolio
- 12.5.5 CritiTech Particle Engineering Solutions Recent Developments
- 12.6 Upperton
- 12.6.1 Upperton Company Information
- 12.6.2 Upperton Business Overview
- 12.6.3 Upperton Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.6.4 Upperton Inhalation Formulation Development Services Product Portfolio
- 12.6.5 Upperton Recent Developments
- 12.7 Tepnel
- 12.7.1 Tepnel Company Information
- 12.7.2 Tepnel Business Overview
- 12.7.3 Tepnel Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.7.4 Tepnel Inhalation Formulation Development Services Product Portfolio
- 12.7.5 Tepnel Recent Developments
- 12.8 Intertek
- 12.8.1 Intertek Company Information
- 12.8.2 Intertek Business Overview
- 12.8.3 Intertek Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.8.4 Intertek Inhalation Formulation Development Services Product Portfolio
- 12.8.5 Intertek Recent Developments
- 12.9 Quotient Sciences
- 12.9.1 Quotient Sciences Company Information
- 12.9.2 Quotient Sciences Business Overview
- 12.9.3 Quotient Sciences Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.9.4 Quotient Sciences Inhalation Formulation Development Services Product Portfolio
- 12.9.5 Quotient Sciences Recent Developments
- 12.10 Medicilon
- 12.10.1 Medicilon Company Information
- 12.10.2 Medicilon Business Overview
- 12.10.3 Medicilon Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.10.4 Medicilon Inhalation Formulation Development Services Product Portfolio
- 12.10.5 Medicilon Recent Developments
- 12.11 Leadingpharm Medical Technology
- 12.11.1 Leadingpharm Medical Technology Company Information
- 12.11.2 Leadingpharm Medical Technology Business Overview
- 12.11.3 Leadingpharm Medical Technology Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.11.4 Leadingpharm Medical Technology Inhalation Formulation Development Services Product Portfolio
- 12.11.5 Leadingpharm Medical Technology Recent Developments
- 12.12 Lonza
- 12.12.1 Lonza Company Information
- 12.12.2 Lonza Business Overview
- 12.12.3 Lonza Revenue in Inhalation Formulation Development Services Business (2021-2026)
- 12.12.4 Lonza Inhalation Formulation Development Services Product Portfolio
- 12.12.5 Lonza Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst